{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:06:24Z","timestamp":1792267584227,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejmech.2024.116527","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:11:21Z","timestamp":1716592281000},"page":"116527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments"],"prefix":"10.1016","volume":"274","author":[{"given":"Salma M.","family":"Hefny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek F.","family":"El-Moselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabaweya","family":"El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ammara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferraroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Dessouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz A.","family":"Shaldam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galal","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-5716","authenticated-orcid":false,"given":"Haytham O.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116527_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.116527_bib2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.116527_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18632\/oncotarget.5684","article-title":"Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo","volume":"6","author":"Guan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116527_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.114004","article-title":"Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine\u2013Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors","volume":"228","author":"Abdel-Mohsen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2022.122537","article-title":"Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors","volume":"631","author":"Eldehna","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2024.116527_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2013.10.027","article-title":"Development and biological evaluation of 99 mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers","volume":"71","author":"Akurathi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2023.106399","article-title":"PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors","volume":"133","author":"Nerella","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2024.116170","article-title":"pH regulators and their inhibitors in tumor microenvironment","volume":"267","author":"Liao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","article-title":"Activation of \u03b1-, \u03b2-, \u03b3- \u03b4-, \u03b6- and \u03b7- class of carbonic anhydrases with amines and amino acids: a review","volume":"34","author":"Akocak","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/14756366.2022.2055553","article-title":"4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies","volume":"37","author":"Nada","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib11","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.112112","article-title":"Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells","volume":"190","author":"Petreni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.202200180","article-title":"Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity","volume":"355","author":"Abdel-Mohsen","year":"2022","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2024.116527_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","article-title":"Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"87","author":"Abo-Ashour","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib18","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/1078-0432.CCR-10-0728","article-title":"Pazopanib in renal cell carcinoma","volume":"16","author":"Ward","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116527_bib19","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1158\/1078-0432.CCR-11-1734","article-title":"The European medicines agency review of pazopanib for the treatment of advanced renal cell carcinoma: summary of the scientific assessment of the committee for medicinal products for human use","volume":"17","author":"Nieto","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116527_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom9110668","article-title":"FDA-and EMA-approved tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer: safety, tolerability, plasma concentration monitoring, and management","volume":"9","author":"Solassol","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.116527_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.103222","article-title":"Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors","volume":"92","author":"Yamali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2023.107089","article-title":"Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: design, synthesis and anti-proliferative activity","volume":"144","author":"Higazy","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116527_bib23","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmc.2016.06.005","article-title":"Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6-dihydropyrimidine\u2013benzenesulfonamides acting as carbonic anhydrase inhibitors","volume":"24","author":"Vullo","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acs.jmedchem.2c01668","article-title":"Ligand-based design on the dog-bone-shaped BIBR1532 pharmacophoric features and synthesis of novel analogues as promising telomerase inhibitors with in vitro and in vivo evaluations","volume":"66","author":"Al-Karmalawy","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib26","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.bmc.2014.08.001","article-title":"Arylazolyl(azinyl)thioacetanilides. Part 16: structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors","volume":"22","author":"Li","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib27","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.jmedchem.6b01804","article-title":"Discovery of benzenesulfonamides with potent human carbonic anhydrase inhibitory and effective anticonvulsant action: design, synthesis, and pharmacological assessment","volume":"60","author":"Mishra","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2020.104059","article-title":"Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme","volume":"102","author":"El-Adl","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/jo902394y","article-title":"Br\u00f8nsted base-catalyzed one-pot three-component Biginelli-type reaction: an efficient synthesis of 4, 5, 6-triaryl-3, 4-dihydropyrimidin-2 (1 H)-one and mechanistic study","volume":"75","author":"Shen","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib30","doi-asserted-by":"crossref","first-page":"27125","DOI":"10.1039\/C9RA03336J","article-title":"Tuning the Biginelli reaction mechanism by the ionic liquid effect: the combined role of supported heteropolyacid derivatives and acidic strength","volume":"9","author":"Freitas","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116527_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2022.114190","article-title":"Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach","volume":"232","author":"Tawfik","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.jmedchem.3c01708","article-title":"Lead optimization of BIBR1591 to improve its telomerase inhibitory activity: design and synthesis of novel four chemical series with in silico, in vitro, and in vivo preclinical assessments","volume":"67","author":"Al-Karmalawy","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ma13040909","article-title":"Thioglycolic acid FTIR spectra on Ag(2)S quantum dots interfaces","volume":"13","author":"Kondratenko","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.ejmech.2024.116527_bib34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the management of glaucoma","volume":"67","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2023.2203389","article-title":"Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors","volume":"38","author":"Shaldam","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib36","first-page":"1","article-title":"Tumor associated carbonic anhydrase inhibitors: rational approaches, design strategies, structure activity relationship and mechanistic insights","volume":"10","author":"Nerella","year":"2024","journal-title":"Eur. J. Med. Chem.Rep."},{"key":"10.1016\/j.ejmech.2024.116527_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.jmedchem.3c02190","article-title":"Synthetic approaches to novel human carbonic anhydrase isoform inhibitors based on pyrrol-2-one moiety","volume":"67","author":"Al-Matarneh","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib38","first-page":"1","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in silico investigations of coumarin-based thiazoles","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2023.215485","article-title":"Control of metalloenzyme activity using photopharmacophores","volume":"499","author":"Mafy","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116527_bib40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1080\/14756366.2020.1781846","article-title":"Human carbonic anhydrases and post-translational modifications: a hidden world possibly affecting protein properties and functions","volume":"35","author":"Di Fiore","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.111600","article-title":"Carbonic anhydrase inhibitors based on sorafenib scaffold: design, synthesis, crystallographic investigation and effects on primary breast cancer cells","volume":"182","author":"Bozdag","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","article-title":"2-Benzylpiperazine: a new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents","volume":"151","author":"Chiaramonte","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2024.107192","article-title":"A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells","volume":"145","author":"Debnath","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22168808","article-title":"Betulin sulfonamides as carbonic anhydrase inhibitors and anticancer agents in breast cancer cells","volume":"22","author":"G\u00fcttler","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116527_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2024.107101","article-title":"Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities","volume":"143","author":"Elsebaie","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116527_bib46","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/acs.jmedchem.8b00384","article-title":"Discovery of novel pazopanib-based HDAC and VEGFR dual inhibitors targeting cancer epigenetics and angiogenesis simultaneously","volume":"61","author":"Zang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2024.116527_bib47","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1021\/acs.jmedchem.3c00640","article-title":"Discovery, synthesis, and evaluation of novel dual inhibitors of a vascular endothelial growth factor receptor and poly(ADP-ribose) polymerase for BRCA wild-type breast cancer therapy","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2018.04.005","article-title":"Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors","volume":"78","author":"Sun","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116527_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2024.116527_bib51","first-page":"1","article-title":"A systematic study of HIF1A cofactors in hypoxic cancer cells","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116527_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cmdc.201600012","article-title":"Targeting protein\u2013protein interactions in the HIF system","volume":"11","author":"Wilkins","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116527_bib53","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1016\/j.bmcl.2011.06.099","article-title":"Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors","volume":"21","author":"Tan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116527_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222413405","article-title":"Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors","volume":"22","author":"Kalinin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116527_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.ejmech.2024.116527_bib56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/02841860902974175","article-title":"Apoptosis in cancer: key molecular signaling pathways and therapy targets","volume":"48","author":"Burz","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ejmech.2024.116527_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BST20120345","article-title":"The impact of hypoxia on cell death pathways","volume":"41","author":"Lenihan","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2024.116527_bib58","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.apcsb.2021.01.003","article-title":"Chapter Four - intrinsic and extrinsic pathways of apoptosis: role in cancer development and prognosis","author":"Kashyap","year":"2021"},{"key":"10.1016\/j.ejmech.2024.116527_bib59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2024.116527_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radmp.2020.01.006","article-title":"HIF-1 signaling: a key orchestrator of cancer radioresistance","volume":"1","author":"Huang","year":"2020","journal-title":"Radia. Med.Prot."},{"key":"10.1016\/j.ejmech.2024.116527_bib61","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/jcp.2003.015032","article-title":"The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis","volume":"57","author":"Greijer","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ejmech.2024.116527_bib62","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0006-2952(02)01155-3","article-title":"Is HIF-1\u03b1 a pro-or an anti-apoptotic protein?","volume":"64","author":"Piret","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116527_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10495-016-1323-5","article-title":"Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival","volume":"22","author":"Pu","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2024.116527_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/cdd.2012.156","article-title":"Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis","volume":"20","author":"Beaudouin","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2024.116527_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1073\/pnas.97.2.529","article-title":"Bax-induced apoptotic cell death","volume":"97","author":"Pawlowski","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116527_bib66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/cdd.2013.139","article-title":"Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis","volume":"21","author":"Westphal","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2024.116527_bib67","article-title":"Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy","volume":"32","author":"Elebiyo","year":"2022","journal-title":"Cancer Treat.Res.Comm."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116527_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07150-3","article-title":"Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis","volume":"20","author":"Azevedo Martins","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2024.116527_bib69","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420944476","article-title":"Role of bee venom and melittin on restraining angiogenesis and metastasis in \u03b3-irradiated solid ehrlich carcinoma-bearing mice","volume":"19","author":"El Bakary","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ejmech.2024.116527_bib70","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s13402-021-00602-3","article-title":"Angiogenesis as a hallmark of solid tumors-clinical perspectives","volume":"44","author":"Majidpoor","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejmech.2024.116527_bib71","article-title":"IL-6: the link between inflammation, immunity and breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116527_bib72","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s12010-022-04266-z","article-title":"Regulatory components of oxidative stress and inflammation and their complex interplay in carcinogenesis","volume":"195","author":"Dharshini","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116527_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154664","article-title":"Oxidative stress affects the beginning of the growth of cancer cells through a variety of routes","author":"Saleh","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116527_bib74","article-title":"Expression levels of caspase\u20103 and gasdermin E and their involvement in the occurrence and prognosis of lung cancer","volume":"5","author":"Huang","year":"2022","journal-title":"Cancer Rep."},{"key":"10.1016\/j.ejmech.2024.116527_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120497","article-title":"Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the Notch signaling pathway modulation","volume":"299","author":"Abd El-Salam","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.116527_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120606","article-title":"Oxidative stress imposed in vivo anticancer therapeutic efficacy of novel imidazole-based oxidovanadium (IV) complex in solid tumor","volume":"301","author":"Ghosh","year":"2022","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116527_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271895","article-title":"Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center","volume":"17","author":"Aynalem","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116527_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15040481","article-title":"New genetic bomb trigger: design, synthesis, molecular dynamics simulation, and biological evaluation of novel BIBR1532-related analogs targeting telomerase against non-small cell lung cancer","volume":"15","author":"Tawfik","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116527_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2023.106799","article-title":"Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: design, synthesis, biological evaluation, kinome selectivity and in silico insights","volume":"140","author":"Elsebaie","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2023.135952","article-title":"New pyrimidinothiophene derivatives: synthesis, spectroscopic analysis, X-ray, DFT calculation, biological activity studies and ADMET prediction","volume":"1290","author":"Ding","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116527_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.116527_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2022.106309","article-title":"Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX\/XII inhibitors: a new regioisomerism tactic","volume":"131","author":"El-Malah","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib83","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1021\/acsomega.2c07285","article-title":"Terminators or guardians? Design, synthesis, and cytotoxicity profiling of chalcone-sulfonamide hybrids","volume":"8","author":"Aboukhatwa","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116527_bib84","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1080\/14756366.2022.2130285","article-title":"Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib85","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib86","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe 131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib87","first-page":"1","article-title":"Induction and testing of hypoxia in cell culture","volume":"54","author":"Wu","year":"2011","journal-title":"JoVE"},{"key":"10.1016\/j.ejmech.2024.116527_bib88","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1039\/D3MD00751K","article-title":"Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through molecular hybridization strategy","volume":"15","author":"Abdelrahman","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib89","series-title":"Processing Diffraction Data with Mosflm","first-page":"41","author":"Leslie","year":"2007"},{"key":"10.1016\/j.ejmech.2024.116527_bib90","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2024.116527_bib91","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2024.116527_bib92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03c6,\u03c8 and C\u03b2 deviation, Proteins: structure","volume":"50","author":"Lovell","year":"2003","journal-title":"Function. Bioinfo."},{"key":"10.1016\/j.ejmech.2024.116527_bib93","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib94","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1016\/j.bmcl.2011.10.057","article-title":"Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents","volume":"21","author":"Ahsan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116527_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2021.105173","article-title":"Synthesis, antitubercular, antimicrobial activities and molecular docking study of quinoline bearing dihydropyrimidines","volume":"115","author":"Desai","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116527_bib96","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:23:40Z","timestamp":1719311020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":96,"alternative-id":["S0223523424004070"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116527","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116527"}}